ArticleJournal of the National Cancer Institute2012

Cost-effectiveness analysis of screening for KRAS and BRAF mutations in metastatic colorectal cancer.

Ajay S Behl et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.